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in the protein-coding part of the genome are more likely to have a
functional consequence.
Methods: The Rotterdam study is a large prospective study population
of over 15.000 individuals ages 45 years and older all living in the
Ommoord district of Rotterdam in the Netherlands. The ﬁrst partic-
ipants were recruited in 1990, and 4 follow-up visits have been done so
far, while continuous monitoring through general practitioners and
pharmacies is also in place. All of the participants were deeply phe-
notyped for osteoarthritis by radiographs and questionnaires. For 1,524
participants, whole exome-sequencing has been performed at a mean
coverage of 40x per base. This allows to ﬁnd novel rare variants, not
identiﬁed previously. We aim to identify functional variants associated
with hipOA and its endophenotype, minimal joint space width (mJSW)
a proxy for cartilage thickness in the hip joint. Our approach included a
candidate gene approach for all genes previously found associated with
hipOA. In addition, we conducted exome-wide association analysis on
all variants found (199 cases, Kellgren-Lawrence grading 2; 1337
Table 1
Variants found in OA candidate genes in the Rotterdam Study – 1 cohort
Candidate OA gene Variants Singletons Synonymous Nonsynonymous Intronic
ASTN2 77 49 11 12 5
DIO2 18 13 4 1 0
DOT1L 117 89 7 8 13
FGFR3 72 47 11 4 10
FILIP1 41 27 6 7 1
GLT8D1 16 14 1 0 1
GNL3 25 18 22 3 2
MCF2L 126 86 16 14 10
NCOA3 122 107 4 8 3
PIK3R1 2 1 0 1 0
PTHLH 13 12 0 0 1
RUNX2 14 12 1 3 1
SENP6 118 101 3 9 5
Table 2
Variants associated to mJSW and hipOA in the Rotterdam Study – I cohort
A. Single-variant analysis
Discovery
Variant Chr Position Reference allele Variant allele Gene Type Phenotype Frequency SE P N
rs3U5898yz 4 1807922 G A FGFR3 Intronic mJSW 0.0099 0.1896 4.92E-06 1006
rs138836456 9 119568036 G A ASTN2 Synonymous mJSW 0.0027 0.3435 5.01E-03 1097
rs114754024yz 4 1806044 C T FGFR3 Intronic hipOA* 0.0083 0.5006 7.90E-03 1082
*Kellgren-Lawrence Grading 2
ySome intronic/intergenic regions are present in exome-sequencing data
zVariants not in linkage disequilibrium r2 < 0.1
B. Candidate gene Burden test
Gene Chr Position Variants Phenotype P
FGFR3 4 1801219 – 1807922 17 mJSW/HipOA* 8.68E-05
TFGa 2 70677994 – 70677994 1 mJSW 0.00786678
NCOA3 20 46256424 - 46280031 9 HipOA 0.0163782
*Kellgren-Lawrence Grading 2controls) and mJSW (minimal cartilage thickness in mm) as the phe-
notypes of interest.
Results: We analyzed in total 199 hipOA cases and 1337 controls,
while we had in total 1242 individuals available with data for mJSW.
To investigate if other coding variants associated to hipOA and mJSW
might be located in the previously identiﬁed hipOA genes, we ana-
lyzed a group of 13 candidate genes in our exome sequencing data
(see table 1). This list includes also 3 genes we identiﬁed to be
associated to mJSW with a GWAS meta-analysis (FGFR3, RUNX2, and
TGFa). We identiﬁed 761 variants in these genes, from which the
majority was found only once (576 singletons). Of the remaining
variants, 70 were non-synonymous, 86 synonymous and 52 intronic;
these variants (excluding the singletons) were analyzed further. Wenext performed gene-based rare-variant tests on these hipOA genes,
by comparing the burden, i.e. amount of rare variants, in OA cases
compared to controls. In 3 candidate genes a nominal signiﬁcant hit
was found (FGFR3, TGFa and NCOA3), after Bonferroni correction
only FGFR3(p ¼ 8.68E-05) remained highly signiﬁcant. The single-
variant analysis yielded 3 signals with a strong association to the
mJSW or hipOA in the exome sequencing data set (p < 10E-2, see
table 2A). The strongest signal for mJSW was a rare variant in the
FGF3 gene, the same gene also identiﬁed in the gene speciﬁc burden
test. This rare variant was not associated to the GWAS signal iden-
tiﬁed before by us (r2 < 0.1). FGFR3 has previously been shown to
be involved in endochondral bone formation. In addition, mutations
in FGFR3 result in achondroplasia.
Conclusions: We identiﬁed rare variants in the FGF3 gene to be asso-
ciated with extreme values of mJSW. Currently we are working on
replication of these ﬁndings. Future analysis will consist of further
functional assessment of the identiﬁed variants.405
EXPRESSION PROFILING OF SUBCHONDRAL BONE IN
OSTEOARTHRITIS KNEE JOINT TISSUE
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Yokohama, Japan; z Inst. of BioMed. Sci., Academia Sinica, Taipei,
Taiwan; xDuke Univ. Med. Ctr., Durham, NC, USA; k Tri-Service Gen.
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Purpose: Osteoarthritis (OA) is a disease of the whole joint organ
involving pathological changes of articular cartilage (AC), structural
changes of underlying subchondral bone (SB) and synovitis. Many
studies utilizing expression array chip technology have been performed
on AC, however, very few has been performed on the SB. We have
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S228developed a novel method for isolating site-matched overlying AC and
underlying SB from regions of interest respectively from the human
knee tibial plateau. Thus, in this study we aimed to evaluate for the ﬁrst
time the differences in gene expression proﬁles of human normal and
osteoarthritic subchondral bone.
Methods: The severity of bone abnormality was ﬁrst determined by
microcomputed tomography. An optimized RNA extraction procedure
was also developed to extract high quality total RNA from regions of
interest from human OA (n ¼ 20) and non-OA (n ¼ 5) knee lateral (LT)
and medial tibial plateaus (MT). Whole-genome expression proﬁling
study was performed using the Agilent Whole Human Genome
Microarray 4x44K Kit with the data analyzed by Agilent GeneSpring
GX11.5. The expression of the 85 genes identiﬁed bymicroarray to show
differential expression was validated using quantitative reverse-tran-
scription polymerase chain reaction (qRT-PCR) analysis on nine OA.
Immunohistochemical staining was also performed to conﬁrm the
expression analysis ﬁndings. Ingenuity Pathway Analysis (IPA) was used
to investigate pathways analysis to determine whether new novel
pathway in OA could be identiﬁed.
Results: A total of 972 deferentially expressed genes with greater than
two fold change were identiﬁed between normal and damaged regions
from the subchondral bone isolated from OA knee joint tissues. The
qRT-PCR and Immunohistochemical data validated the accuracy of
microarray results with high degree (R2 ¼ 0.5764, P < 0.0001). Pathway
analysis showed that these genes were clustered in 279 canonical
pathways and several novel pathways were identiﬁed, including
phosphor-v-akt murine thymoma viral oncogene homolog 1 (p-AKT),
Periostin (POSTN), and Leptin (LEP), which implicated the involvement
of bone remodeling by osteoblasts.
Conclusions: To the best of our knowledge, this study represents the
ﬁrst and the most comprehensive direct assessment of gene expression
proﬁling conducted in OA subchondral bone. With the ability to directly
studying genetic proﬁles of subchondral bone could further the
understanding of the parthenogenesis of the disease.
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FUNCTIONAL ANALYSIS OF THE OSTEOARTHRITIS SUSCEPTIBILITY
LOCUS RESIDING AT THE CARBOHYDRATE SULFOTRANSFERASE 11
GENE CHST11
L.N. Reynard, M. Ratnayake, M. Santibanez-Koref, J. Loughlin. Newcastle
Univ., Newcastle upon Tyne, United Kingdom
Purpose: CHST11 encodes an enzyme that catalyses the transfer of
sulphate groups to chondroitin to form chondroitin-4-sulphate, a major
component of glycosaminoglycan (GAG) chains in the cartilage extrac-
ellular matrix. The single nucleotide polymorphism (SNP) rs835487
that is located within intron 2 of CHST11 is associated with hip OA, at
the genome-wide signiﬁcance level, with a p-value of 1.64x10-8. The
aim of this study was to 1) assess the role of CHST11 in cartilage
development and homeostasis, and 2) identify the causal allele or
alleles that account for the OA association signal and determine how
this acts to increase susceptibility to the disease.
Methods: The CHST11 open reading frame (ORF) was sequenced in 200
hip OA patients. CHST11 expression in normal and osteoarthritic carti-
lage was assessed using quantitative PCR. CHST11 protein was depleted
or overexpressed in human iliac crest derived mesenchymal stem cells
(MSCs) followed by chondrogenic differentiation using siRNAs and
lentivirus transduction, respectively. SNPs in linkage disequilibrium
(LD) with the association SNP rs835487 were identiﬁed and their
function tested using luciferase enhancer assays in the human chon-
drosarcoma cell line SW1353. Allelic differences in enhancer activity
were analysed further using electrophoretic mobility shift assays
(EMSAs) and transcription factor prediction tools to identify trans-act-
ing factors that bind to these functional SNPs.
Results: There are no common amino acid changes within CHST11,
indicating that the OA susceptibility has to be mediated by a cis-acting
regulatory polymorphism that inﬂuences CHST11 expression. CHST11 is
upregulated 2.6 fold in OA hip cartilage relative to non-OA hip cartilage
(p ¼ 0.007). CHST11 depletion caused a 27% reduction (p ¼ 0.005) and
CHST11 overexpression a 22% increase (p ¼ 0.015) in the wet weight of
cartilage discs formed by chondrogenic differentiation of MSCs.
Expression of SOX9, COL2A1 and ACAN were down-regulated and
RUNX2, MMP13 and ADAMTS5 up-regulated in cartilage discs formed
from CHST11 knock-down MSCs relative to the control non-targeting
siRNA. Micromass cultures of MSCs after CHST11 protein knock-downalso had reduced GAG sulfation as determined by quantiﬁcation of
Alcian Blue staining. We identiﬁed six candidate SNPs within the OA
association interval which is located within a region predicted to have
transcriptional enhancer activity. There was differential enhancer
activity of the two alleles of the rs835487 and rs835488 SNPs; these two
SNPs are in perfect LD and our data suggests that they have an additive
or synergistic effect on enhancer activity. EMSA supershift studies
demonstrated that the transcription factors SP1, SP3 and SUB1 bind to
both rs835487 and rs835488, with YY1 binding speciﬁcally over the
rs835488 SNP. These proteins bind more avidly to the OA-associated
alleles of rs835487 and rs835488 than the non-OA associated alleles.
Conclusions: CHST11 plays an important role in chondrogenesis, with
loss of the protein leading to decreased matrix synthesis and increased
chondrocyte hypertrophy. rs835487 and rs835488 are the top candi-
date SNPs for the OA susceptibility, with the disease associated GT
haplotype of the two SNPs having signiﬁcantly different enhancer
activity relative to the AC haplotype in-vitro. Furthermore, several
transcription factors bind more strongly to the disease-associated
alleles. We conclude that the OA susceptibility residing within CHST11
is mediated by differential protein binding to the alleles of the rs835487
and rs835488 SNPs, which are located within a region that functions as
a cis-acting enhancer of CHST11 transcription.
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ALLELIC EXPRESSION ANALYSIS OF GENES FROM WITHIN THE
OSTEOARTHRITIS SUSCEPTIBILITY LOCUS AT CHROMOSOME 3P21
REVEALS FUNCTIONAL GENE EXPRESSION EFFECTS AT GNL3 AND
SPCS1 THAT CORRELATE WITH THE ASSOCIATION SIGNAL
F.H. Gee, C.F. Clubbs, E.V. Raine, L.N. Reynard, J. Loughlin. Newcastle
Univ., Newcastle Upon Tyne, United Kingdom
Purpose: A genome-wide association scan with subsequent replication
study involving over 67,000 individuals of European ancestry produced
highly signiﬁcant evidence of an association of single nucleotide poly-
morphisms (SNPs) rs6976 and rs11177 to severe primary osteoarthritis
(OA), with p-values of 7.24  1011 and 1.25  1010, respectively. The
two SNPs are in perfect linkage disequilibrium (LD); rs6976 is located in
the 3’UTR of GLT8D1 and rs11177 is a non-synonymous SNP within exon
3 of GNL3. These two genes map to chromosome 3p21.1 and are part of
an association interval that encompasses ten other genes. The amino
acid substitution caused by rs11177 is benign and there are no other
amino acid substitutions within the twelve genes that can account for
the association signal. There is mounting evidence to suggest that most
common complex trait alleles are cis-acting regulatory polymorphisms
that inﬂuence, in a tissue-speciﬁc manner, gene transcription or tran-
script stability, resulting in allelic expression imbalance (AEI). We
therefore used allelic expression analysis to assess whether the OA
association at 3p21.1 is mediated by cis-acting regulatory poly-
morphisms that act on the genes from within the association interval.
Methods:We focused on those genes that are expressed in joint tissues.
We initially measured gene expression by quantitative PCR, using RNA
extracted from the hip cartilage of OA patients who had undergone
elective hip replacement surgery, and of non-OA patients who had
undergone surgery for a neck-of-femur (NOF) fracture. A two-tailed
Mann-Whitney exact test was used to determine whether gene
expression differed signiﬁcantly between the two groups. We then
assessed AEI using pyrosequencing assays that can accurately dis-
tinguish and quantify the mRNA synthesized from both alleles of a
transcript SNP. We used mRNA extracted from the cartilage, fat pad and
synovium of primary OA patients who had undergone elective joint
replacement surgery. DNA from the tissues was used to provide the 1:1
ratio to which the mRNA ratios were compared in the AEI analysis. For
each gene we studied at least 17 informative patients. A two-tailed
Mann-Whitney exact test was used to test the signiﬁcance of any allelic
expression differences.
Results: SPCS1, GLT8D1 and NT5DC2 demonstrated signiﬁcantly higher
expression in hip OA cartilage relative to NOF control cartilage (SPCS1, p
¼ 0.02; GLT8D1, p ¼ 0.02; NT5DC2, p ¼ 0.0005). GNL3 and SPCS1
demonstrated signiﬁcant AEI in OA cartilage (GNL3, mean AEI ¼ 1.04, p
¼ 0.0002; SPCS1, mean AEI ¼ 1.07, p < 0.0001) and in a direction that
correlated with the association signal. Similar AEI results were observed
for these two genes in fat pad and synovial tissue (GNL3, mean AEI ¼
1.04, p ¼ 0.01; SPCS1, mean AEI ¼ 1.09, p ¼ 0.01). For both genes,
expression of the OA-associated allele was lower than that of the non-
associated allele.
